Carina Biotech Doses First Patient in Phase 1/2a Clinical
First patient dosed in Australia where 3 clinical trial sites have been activated.The trial will enrol advanced colorectal cancer patients whose cancer...
Source: globenewswire.com
Page 2 - Recommended Phase News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Recommended Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Recommended Phase Today - Breaking & Trending Today
Bridge Biotherapeutics Announces Initiation of Phase 1/2 Clinical Trial of BBT-207 in EGFR-Mutant NSCLC
/PRNewswire/ -- Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation,...
Source: prnewswire.com
ORYZON Reports Financial Results and Corporate Updates for Quarter Ended September 30, 2023
27.10.2023 - Positive aggregate safety data from vafidemstat's fully enrolled PORTICO Phase IIb trial in Borderline Personality Disorder (BPD), consistent with safety data from seven completed clinical trials, supporting the drug is safe and ...
Source: wallstreet-online.de
Olema Oncology Announces Positive Phase 2 Monotherapy
Across all 86 heavily pretreated patients, the median PFS was 4.6 months with a CBR of 40%; in patients with ESR1 mutations at baseline, the median PFS was...
Source: globenewswire.com
Olema Oncology Announces Positive Phase 2 Monotherapy Clinical Study Results for Palazestrant - Olema Pharmaceuticals (NASDAQ:OLMA)
Across all 86 heavily pretreated patients, the median PFS was 4.6 months with a CBR of 40%; in patients with ESR1 mutations at baseline, the median PFS was 5.6 months with a CBR of 52% In an analysis of 49 second- and
Source: benzinga.com